The angiopoietin/Tie-2 system in proliferative sickle retinopathy: Relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment

British Journal of Ophthalmology

Volumn 89, Issue 7, 2005, Pages 815-819

  Mohan, J S ^a,b   Lip, P L ^b   Blann, A D ^a   Bareford, D ^b   Lip, G Y H ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; HEMOGLOBIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VON WILLEBRAND FACTOR;

ADULT; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; LASER COAGULATION; LOW LEVEL LASER THERAPY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; PROLIFERATIVE SICKLE RETINOPATHY; PROTEIN PROTEIN INTERACTION; RETINOPATHY;

ADULT; ANEMIA, SICKLE CELL; ANGIOPOIETIN-1; ANGIOPOIETIN-2; ANGIOPOIETINS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LASER COAGULATION; MALE; RECEPTOR, TIE-2; RETINAL DISEASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VON WILLEBRAND FACTOR;

EID: 21344466054     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2004.058164     Document Type: Article

References (20)

1. Moriarty BJ, Acheson RW, Condon PI, et al. Patterns of visual loss in untreated sickle cell retinopathy. Eye 1988;2:330-5.
2. Goldberg MF. Natural history of untreated proliferative sickle retinopathy. Arch Ophthalmol 1971;85:428-37.
3. Fox PD, Rupert Vessey SJ, Forshaw ML, et al. Influence of genotype on the natural history of untreated proliferative sickle retinopathy - an angioraphic study. Br J Ophthalmol 1991;75:229-31.
4. Shima DT, Deutsch U, D'Amore PA. Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability. FEBS Lett 1995;370:203-8.
5. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994;331:1480-7.
6. Aiello LP, Northrup JM, Keyt BA, et al. Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol 1995;113:1538-44.
7. Lip PL, Belgore F, Blann AD, et al. Plasma VEGF and soluble VEGF receptor Flt-1 in proliferative retinopathy; relationship to endothelial dysfunction and laser treatment. Invest Ophthalmol Vis Sci 2000;41:2115-19.
8. Barleon B, Hauser S, Schollmann C, et al. Differential expression of the two VEGF receptors fit and KDR in placenta and vascular endothelial cells. J Cell Biochem 1994;54:56-66.
9. Maisonpierre PC, Suri C, Jones PF, et al. Angiopoietin-2, a natural antagonist for Tie-2 that disrupts in vivo angiogenesis. Science 1997;277:55-60.
10. Holash J, Maisonpierre PC, Compton D, et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 1999;284:1994-8.
11. Holash J, Wiegand SJ, Yancopoulos GD. New model of tumor ongiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 1999;18:5356-62.
12. Mandriota SJ, Pepper MS. Regulation of ongiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia. Circ Res 1998;83:852-9.
13. Oh H, Takagi H, Suzuma K, et al. Hypoxia and vascular endothelial growth factor selectively up-regulateangiopoietin-2 in bovine microvascular endothelial cells. J Biol Chem 1999;274:15732-9.
14. Otani A, Takagi H, Oh H, et al. Expressions of angiopoietins and Tie-2 inhuman choroidal neovascular membranes. Invest Ophthalmol Vis Sci 1999;40:1912-20.
15. Solovey A, Gui L, Ramakrishnan S, et al. Sickle cell anemia as a possible state of enhanced anti-apoptotic tone: survival effect of vascular endothelial growth factor on circulating and unanchored endothelial cells. Blood 1999;93:3824-30.
16. Blann AD, Marwah S, Serjeant G, et al. Platelet activation and endothelial cell dysfunction in sickle cell disease is unrelated to reduced antioxidant capacity. Blood Coag Fibrinolys 2003;14:255-9.
17. Kim I, Kim HG, So JN, et al. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3′-Kinase/Akt signal transduction pathway. Circ Res 2000;86:24-9.
18. Harfouche R, Hassessian HM, Guo Y, et al. Mechanisms which mediate the antiapoptotic effects of angiopoietin-1 on endothelial cells. Microvasc Res 2002;64:135-47.
19. Takagi H, Koyama S, Seike H, et al. Potential role of the angiopoietin/Tie-2 system in ischemia-induced retinal neovascularization. Invest Ophthalmol Vis Sci 2003;44:393-402.
20. Cao J, Mathews MK, McLeod DS, et al. Angiogenic factors in human proliferate sickle cell retinopathy. Br J Ophthalmol 1999;83:838-46.